Nanopath Co-founders Amogha Tadimety and Alison Burklund, both Ph.Ds from Dartmouth’s School of Engineering, are innovating new technologies to become the go-to provider for routine women’s health screenings at the point of care. They launched their molecular diagnostics start-up in 2019 in partnership with the Dartmouth Hitchcock Medical Center.